OncoSec Medical Incorporated Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

Stockholders' Equity (Details Narrative) - USD ($)					3 Months Ended		9 Months Ended
Stockholders' Equity (Details Narrative) - USD ($)	Feb. 06, 2018	Nov. 13, 2017	Oct. 25, 2017	Jul. 25, 2017	Apr. 30, 2018	Apr. 30, 2017	Apr. 30, 2018	Apr. 30, 2017
Number of shares issued on public offering	13,333,334
Offering price per share	$ 1.50
Gross proceeds from offering	$ 23,000,000						$ 28,636,232
Underwriting fees	1,700,000
Offering expenses	500,000
Net proceeds from issuance of public offering	$ 20,800,000						$ 35,809
Warrant to purchase shares of common stock					8,958,059		8,958,059
Proceeds from cash exercise of warrants							$ 9,999,983	30,950
Warrant inducement expense							$ 2,465,396
Warrant expire term							These warrants expire at various dates between September 2018 and May 2025.
Maximum [Member]
Warrant exercise price per share					$ 18.00		$ 18.00
Minimum [Member]
Warrant exercise price per share					$ 1.25		$ 1.25
First October 2017 Offerings [Member]
Fair value of warrants			$ 2,400,000
Dividend rate
Expected term of volatility			5 years 6 months
Volatility rate			75.55%
Risk-free interest rate			2.12%
First October 2017 Offerings [Member] \| Placement Agent [Member]
Gross proceeds from offering			$ 7,100,000
Offering expenses			$ 60,000
Warrant to purchase shares of common stock			316,256
Warrant exercise price per share			$ 1.68
Proceeds from cash exercise of warrants			$ 6,200,000
Warrant expiry date			Oct. 21, 2022
Fair value of warrants			$ 200,000
Dividend rate
Expected term of volatility			5 years
Volatility rate			73.25%
Risk-free interest rate			2.06%
Percentage of gross proceeds of offering			5.50%
Second October 2017 Offerings [Member]
Fair value of warrants			$ 400,000
Dividend rate
Expected term of volatility			5 years 6 months
Volatility rate			75.51%
Risk-free interest rate			2.12%
Second October 2017 Offerings [Member] \| Placement Agent [Member]
Offering expenses			$ 15,000
Warrant to purchase shares of common stock			48,000
Warrant exercise price per share			$ 1.68
Warrant expiry date			Oct. 25, 2022
Fair value of warrants			$ 31,000
Dividend rate
Expected term of volatility			5 years
Volatility rate			73.22%
Risk-free interest rate			2.06%
Percentage of gross proceeds of offering			5.50%
Accredited Investors [Member] \| First October 2017 Offerings [Member]
Warrant to purchase shares of common stock			3,953,200
Warrant exercise price per share			$ 1.25
Warrant exercisable date			Oct. 25, 2017
Warrant expiry date			Apr. 25, 2022
Number of common stock shares sold under offering			5,270,934
Purchase price per share			$ 1.34375
One Accredited Investors [Member] \| Second October 2017 Offerings [Member]
Gross proceeds from offering			$ 1,100,000
Warrant to purchase shares of common stock			600,000
Warrant exercise price per share			$ 1.25
Proceeds from cash exercise of warrants			$ 1,000,000
Warrant exercisable date			Apr. 27, 2018
Warrant expiry date			Apr. 27, 2022
Number of common stock shares sold under offering			800,000
Purchase price per share			$ 1.34375
Warrant Exercise Agreement [Member]
Warrant to purchase shares of common stock		5,509,642
Warrant exercise price per share		$ 1.69
Gross proceeds from exercise of warrants		$ 9,300,000
Proceeds from cash exercise of warrants		$ 9,100,000
Warrant Exercise Agreement [Member] \| Accredited Investors [Member]
Warrant to purchase shares of common stock		1,138,300
Fair value of warrants		$ 2,500,000
Dividend rate		0.00%
Expected term of volatility		2 years
Volatility rate		73.12%
Risk-free interest rate		1.70%
Warrant Exercise Agreement [Member] \| New Warrants [Member]
Warrant to purchase shares of common stock		1,377,411
Warrant exercise price per share		$ 2.26
Percentage of warrant to purchase common stock equal to common stock received		25.00%
Warrant exercisable date		May 13, 2018
Warrant expiry date		Nov. 13, 2019
Equity Distribution Agreement [Member] \| Oppenheimer & Co. Inc [Member]
Number of common stock shares sold under offering							897,311
Other expenses							$ 1,100,000
Equity Distribution Agreement [Member] \| Oppenheimer & Co. Inc [Member] \| Maximum [Member]
Net proceeds from issuance of public offering				$ 8,400,000
Over Allotment Option [Member]
Number of shares issued on public offering	2,000,000
Offering price per share	$ 1.50